EFRELand Brandenburgbe Berlin

The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value- added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.

With more than 240 biotechnology companies, 30 pharmaceutical companies, 35 major research facilities and institutions of higher education with a life sciences focus and over 130 clinics, Berlin-Brandenburg is already a European hot spot for the life sciences. Growth in expertise, players and investment will reinforce the capital region’s leading position in the international markets.